SBIR/STTR Research Award
Novel prostate homing peptides as potential diagnostics
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TARGETED MOLECULES CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): In vivo panning with phage display
libraries has proved to be a powerful method to identify novel vascular
bed-specific peptide homing sequences. In this application we propose to study
the binding characteristics of a newly identified prostate endothelial-specific
sequence. The relative contribution of affinity and avidity will be studied by
assessing the effect of peptide copy number on phage homing in vivo as well as
binding affinity to cells isolated from the prostate in vitro. The critical
amino acid residues within this prostate-specific heptapeptide sequence will be
determined. We also propose to screen for additional prostate specific peptides
by screening the CX3CX3C and CX6C phage display libraries, since these yield
cyclic peptides that may exhibit higher binding affinities. By better
understanding the binding requirements as well as the homing potential in
normal compared to developing tumor tissue, these studies will provide
essential fundamental information required to translate specific peptides
identified with a multivalent phage display system into practical therapeutic
or diagnostic tools for prostate hypertrophy and cancer.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported